Use your antibodies-online credentials, if available.
Select your species
increased KLK14 activity could contribute at multiple levels to HGF (显示 HGF ELISA试剂盒)/Met-mediated processes in prostate and other cancers
KLK7 (显示 KLK7 ELISA试剂盒) and KLK14 gene expression can be regarded as markers of poor prognosis for colorectal cancer patients with discriminating power between CC and adenoma patients.
genetic variants in the KLK14 locus are associated with risk and/or aggressiveness of prostate cancer
KLK14, acting via PAR-2 (显示 F2RL1 ELISA试剂盒), represents an autocrine/paracrine regulator of colon tumorigenesis
KLK8 (显示 KLK8 ELISA试剂盒) and KLK14 can signal differentially via the PARs (显示 EPRS ELISA试剂盒) to affect tissue function
KLK14 gene expression could be evaluated as a putative independent diagnostic biomarker in breast tumour biopsies.
The differences in the levels of KLK14 suggest that KLKs may aid in the differential diagnosis of salivary gland tumors. The coexpression of KLKs suggests their possible involvement in an enzymatic pathway activated in salivary gland.
KLK14 overexpression was found to be a significant predictor of decreased disease-free survival and overall survival in breast cancer patients
KLK14 expression upregulated in advanced and more aggressive prostate tumors; may play role in tumor spread and may be new marker for prostate cancer diagnosis and prognosis
hK14 has dual activity, trypsin- and chymotrypsin-like, with a preference for cleavage after arginine residues
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. An additional transcript variant has been described but its full length nature has not been determined.
glandular kallikrein KLK14
, kallikrein 14
, kallikrein-like protein 6